Impact of renal insufficiency on mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention

BMC Cardiovascular Disorders

Volumn 14, Issue , 2014, Pages

  Sabroe, Jonas E ^a   Thayssen, Per ^a   Antonsen, Lisbeth ^a   Hougaard, Mikkel ^a   Hansen, Knud N ^a   Jensen, Lisette O ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Mortality; Renal insufficiency; ST segment elevation myocardial infarction

Indexed keywords

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; COMORBIDITY; CREATININE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RENAL INSUFFICIENCY; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84893690707     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-14-15     Document Type: Article

References (33)

1. Mendis S. Cardiovascular risk assessment and management in developing countries. Vasc Health Risk Manag 2005, 1:15-18. 10.2147/vhrm.1.1.15.58933, 1993930, 17319094.
2. Ichikawa K, Konta T, Ikeda A, Fujimoto S, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Yoshida H, Asahi K, Kurahashi I, Ohashi Y, Watanabe T. Significance of past history of renal failure for the detection of high-risk individuals for cardiovascular and end-stage renal disease: analysis of data from a nationwide health checkup. Clin Exp Nephrol 2011, 15:841-847. 10.1007/s10157-011-0509-y, 21818546.
3. Furuhashi T, Moroi M, Joki N, Hase H, Masai H, Kunimasa T, Nakazato R, Fukuda H, Sugi K. The impact of chronic kidney disease as a predictor of major cardiac events in patients with no evidence of coronary artery disease. J Cardiol 2010, 55:328-336. 10.1016/j.jjcc.2009.12.009, 20350504.
4. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004, 351:1296-1305. 10.1056/NEJMoa041031, 15385656.
5. Meisinger C, Doring A, Lowel H. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population. Eur Heart J 2006, 27:1245-1250.
6. Manjunath G, Tighiouart H, Ibrahim H, Macleod B, Salem DN, Griffith JL, Coresh J, Levey AS, Sarnak MJ. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 2003, 41:47-55.
7. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G, National Kidney F. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003, 139:137-147. 10.7326/0003-4819-139-2-200307150-00013, 12859163, National Kidney F.
8. Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, Miller WL, Murphy JG, Kopecky SL, Jaffe AS. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 2002, 137:563-570. 10.7326/0003-4819-137-7-200210010-00007, 12353943.
9. Menon V, Sarnak MJ, Lessard D, Goldberg RJ. Recent trends in hospital management practices and prognosis after acute myocardial infarction in patients with kidney disease. Am J Cardiol 2004, 94:1290-1293. 10.1016/j.amjcard.2004.07.116, 15541249.
10. Seyfarth M, Kastrati A, Mann JF, Ndrepepa G, Byrne RA, Schulz S, Mehilli J, Schomig A. Prognostic value of kidney function in patients with st-elevation and non-st-elevation acute myocardial infarction treated with percutaneous coronary intervention. Am J Kidney Dis 2009, 54:830-839. 10.1053/j.ajkd.2009.04.031, 19592145.
11. Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van't Hof A, Widimsky P, Zahger D. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J 2012, 33:2569-2619.
12. Fox CS, Muntner P, Chen AY, Alexander KP, Roe MT, Cannon CP, Saucedo JF, Kontos MC, Wiviott SD. Use of evidence-based therapies in short-term outcomes of st-segment elevation myocardial infarction and non-st-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the national cardiovascular data acute coronary treatment and intervention outcomes network registry. Circulation 2010, 121:357-365. 10.1161/CIRCULATIONAHA.109.865352, 2874063, 20065168.
13. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, Abildgaard U, Pedersen F, Madsen JK, Grande P, Villadsen AB, Krusell LR, Haghfelt T, Lomholt P, Husted SE, Vigholt E, Kjaergard HK, Mortensen L. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003, 349:733-742. 10.1056/NEJMoa025142, 12930925.
14. Jensen LO, Maeng M, Kaltoft A, Thayssen P, Hansen HH, Bottcher M, Lassen JF, Krussel LR, Rasmussen K, Hansen KN, Pedersen L, Johnsen SP, Soerensen HT, Thuesen L. Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions. J Am Coll Cardiol 2007, 50:463-470. 10.1016/j.jacc.2007.06.002, 17662400.
15. Michels WM, Grootendorst DC, Verduijn M, Elliott EG, Dekker FW, Krediet RT. Performance of the cockcroft-gault, mdrd, and new ckd-epi formulas in relation to gfr, age, and body size. Clin J Am Soc Nephrol 2010, 5:1003-1009. 10.2215/CJN.06870909, 2879308, 20299365.
16. Rigalleau V, Lasseur C, Perlemoine C, Barthe N, Raffaitin C, Chauveau P, Combe C, Gin H. Cockcroft-gault formula is biased by body weight in diabetic patients with renal impairment. Metabolism 2006, 55:108-112. 10.1016/j.metabol.2005.07.014, 16324928.
17. Fesler P, Mimran A. Estimation of glomerular filtration rate: what are the pitfalls?. Curr Hypertens Rep 2011, 13:116-121. 10.1007/s11906-010-0176-5, 21207252.
18. Hallan S, Asberg A, Lindberg M, Johnsen H. Validation of the modification of diet in renal disease formula for estimating gfr with special emphasis on calibration of the serum creatinine assay. Am J Kidney Dis 2004, 44:84-93. 10.1053/j.ajkd.2004.03.027, 15211442.
19. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB. The danish civil registration system. A cohort of eight million persons. Dan Med Bull 2006, 53:441-449.
20. Epidemiology FL. When an entire country is a cohort. Science 2000, 287:2398-2399. 10.1126/science.287.5462.2398, 10766613.
21. Medi C, Chew DP, Amerena J, Coverdale S, Soman A, Astley C, Rankin J, Brieger D. An invasive management strategy is associated with improved outcomes in high-risk acute coronary syndromes in patients with chronic kidney disease. Intern Med J 2011, 41:743-750. 10.1111/j.1445-5994.2010.02361.x, 21040324.
22. Campbell NG, Varagunam M, Sawhney V, Ahuja KR, Salahuddin N, De PR, Rothman MT, Wragg A, Yaqoob MM, Knight CJ. Mild chronic kidney disease is an independent predictor of long-term mortality after emergency angiography and primary percutaneous intervention in patients with st-elevation myocardial infarction. Heart 2012, 98:42-47. 10.1136/heartjnl-2011-300024, 21880649.
23. Gibson CM, Pinto DS, Murphy SA, Morrow DA, Hobbach HP, Wiviott SD, Giugliano RP, Cannon CP, Antman EM, Braunwald E. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol 2003, 42:1535-1543. 10.1016/j.jacc.2003.06.001, 14607434.
24. Wilson WM, Andrianopoulos N, Clark D, Duffy SJ, Brennan A, Harries I, New G, Sebastian M, Loane P, Reid C, Ajani AE. Long-term predictors of mortality after percutaneous coronary intervention in the era of drug-eluting stents. Am J Cardiol 2011, 108:936-942. 10.1016/j.amjcard.2011.05.024, 21920184.
25. de Mulder M, van der Ploeg T, de Waard GA, Boersma E, Umans VA. Admission glucose does not improve grace score at 6 months and 5 years after myocardial infarction. Cardiology 2011, 120:227-234. 10.1159/000335715, 22343543.
26. Pinkau T, Mann JF, Ndrepepa G, Mehilli J, Hadamitzky M, Braun S, Kastrati A, Schomig A. Coronary revascularization in patients with renal insufficiency: restenosis rate and cardiovascular outcomes. Am J Kidney Dis 2004, 44:627-635. 10.1053/j.ajkd.2004.05.045, 15384013.
27. Morel O, El GS, Jesel L, Radulescu B, Meyer N, Wiesel ML, Caillard S, Campia U, Moulin B, Gachet C, Ohlmann P. Cardiovascular mortality in chronic kidney disease patients undergoing percutaneous coronary intervention is mainly related to impaired p2y12 inhibition by clopidogrel. J Am Coll Cardiol 2011, 57:399-408. 10.1016/j.jacc.2010.09.032, 21251579.
28. Sadeghi HM, Stone GW, Grines CL, Mehran R, Dixon SR, Lansky AJ, Fahy M, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Stuckey TD, Turco M, Carroll JD. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 2003, 108:2769-2775. 10.1161/01.CIR.0000103623.63687.21, 14638545.
29. Bertomeu-Gonzalez V, Nunez J, Nunez E, Facila L, Sanchis J, Bodi V, Pellicer M, Bosch MJ, Martinez A, Chorro FJ, Llacer A. Prognostic effect of renal dysfunction after st-segment elevation myocardial infarction with and without heart failure. Int J Cardiol 2006, 112:159-165. 10.1016/j.ijcard.2005.08.031, 16290104.
30. Heer T, Schiele R, Schneider S, Gitt AK, Wienbergen H, Gottwik M, Gieseler U, Voigtlander T, Hauptmann KE, Wagner S, Senges J. Gender differences in acute myocardial infarction in the era of reperfusion (the mitra registry). Am J Cardiol 2002, 89:511-517. 10.1016/S0002-9149(01)02289-5, 11867033.
31. Hailer B, Naber C, Koslowski B, Van LP, Schafer H, Budde T, Jacksch R, Sabin G, Erbel R. Gender-related differences in patients with st-elevation myocardial infarction: results from the registry study of the st elevation myocardial infarction network essen. Clin Cardiol 2011, 34:294-301. 10.1002/clc.20916, 21557255.
32. Damman P, Kikkert WJ, Woudstra P, Kuijt WJ, Grundeken MJ, Harskamp RE, Baan J, Vis MM, Henriques JP, Piek JJ, van Straalen JP, Fischer JC, Tijssen JG, de Winter RJ. Gender difference in the prognostic value of estimated glomerular filtration rate at admission in st-segment elevation myocardial infarction: a prospective cohort study. BMJ Open 2012, 2(2):e000322. doi:10.1136/bmjopen-2011-000322, 3293134, 22389358.
33. Jensen LO, Maeng M, Thayssen P, Tilsted HH, Terkelsen CJ, Kaltoft A, Lassen JF, Hansen KN, Ravkilde J, Christiansen EH, Madsen M, Sørensen HT, Thuesen L. Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Am J Cardiol 2012, 109:629-635. 10.1016/j.amjcard.2011.10.018, 22152969.